Global Angioedema Treatment Market Research Report 2021

1 Angioedema Treatment Market Overview
1.1 Product Overview and Scope of Angioedema Treatment
1.2 Angioedema Treatment Segment by Type
1.2.1 Global Angioedema Treatment Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Others
1.3 Angioedema Treatment Segment by Application
1.3.1 Angioedema Treatment Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Organizations
1.4 Global Angioedema Treatment Market Size Estimates and Forecasts
1.4.1 Global Angioedema Treatment Revenue 2016-2027
1.4.2 Global Angioedema Treatment Sales 2016-2027
1.4.3 Angioedema Treatment Market Size by Region: 2016 Versus 2021 Versus 2027

2 Angioedema Treatment Market Competition by Manufacturers
2.1 Global Angioedema Treatment Sales Market Share by Manufacturers (2016-2021)
2.2 Global Angioedema Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Angioedema Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Angioedema Treatment Manufacturing Sites, Area Served, Product Type
2.5 Angioedema Treatment Market Competitive Situation and Trends
2.5.1 Angioedema Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Angioedema Treatment Players Market Share by Revenue
2.5.3 Global Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Angioedema Treatment Retrospective Market Scenario by Region
3.1 Global Angioedema Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Angioedema Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Angioedema Treatment Market Facts & Figures by Country
3.3.1 North America Angioedema Treatment Sales by Country
3.3.2 North America Angioedema Treatment Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Angioedema Treatment Market Facts & Figures by Country
3.4.1 Europe Angioedema Treatment Sales by Country
3.4.2 Europe Angioedema Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Angioedema Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific Angioedema Treatment Sales by Region
3.5.2 Asia Pacific Angioedema Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Angioedema Treatment Market Facts & Figures by Country
3.6.1 Latin America Angioedema Treatment Sales by Country
3.6.2 Latin America Angioedema Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Angioedema Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa Angioedema Treatment Sales by Country
3.7.2 Middle East and Africa Angioedema Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Angioedema Treatment Historic Market Analysis by Type
4.1 Global Angioedema Treatment Sales Market Share by Type (2016-2021)
4.2 Global Angioedema Treatment Revenue Market Share by Type (2016-2021)
4.3 Global Angioedema Treatment Price by Type (2016-2021)

5 Global Angioedema Treatment Historic Market Analysis by Application
5.1 Global Angioedema Treatment Sales Market Share by Application (2016-2021)
5.2 Global Angioedema Treatment Revenue Market Share by Application (2016-2021)
5.3 Global Angioedema Treatment Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 F.Hoffmann-La Roche AG
6.2.1 F.Hoffmann-La Roche AG Corporation Information
6.2.2 F.Hoffmann-La Roche AG Description and Business Overview
6.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.2.4 F.Hoffmann-La Roche AG Product Portfolio
6.2.5 F.Hoffmann-La Roche AG Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Corporation Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bausch Health Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Sanofi SA
6.6.1 Sanofi SA Corporation Information
6.6.2 Sanofi SA Description and Business Overview
6.6.3 Sanofi SA Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sanofi SA Product Portfolio
6.6.5 Sanofi SA Recent Developments/Updates
6.7 Merck?Co
6.6.1 Merck?Co Corporation Information
6.6.2 Merck?Co Description and Business Overview
6.6.3 Merck?Co Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck?Co Product Portfolio
6.7.5 Merck?Co Recent Developments/Updates

7 Angioedema Treatment Manufacturing Cost Analysis
7.1 Angioedema Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Angioedema Treatment
7.4 Angioedema Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Angioedema Treatment Distributors List
8.3 Angioedema Treatment Customers

9 Angioedema Treatment Market Dynamics
9.1 Angioedema Treatment Industry Trends
9.2 Angioedema Treatment Growth Drivers
9.3 Angioedema Treatment Market Challenges
9.4 Angioedema Treatment Market Restraints

10 Global Market Forecast
10.1 Angioedema Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Angioedema Treatment by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Angioedema Treatment by Type (2022-2027)
10.2 Angioedema Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Angioedema Treatment by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Angioedema Treatment by Application (2022-2027)
10.3 Angioedema Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Angioedema Treatment by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Angioedema Treatment by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Angioedema Treatment Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Angioedema Treatment Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Angioedema Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Angioedema Treatment Covered in This Study
Table 5. Global Angioedema Treatment Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Angioedema Treatment Sales Share by Manufacturers (2016-2021)
Table 7. Global Angioedema Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Angioedema Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Angioedema Treatment Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Angioedema Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers Angioedema Treatment Product Type
Table 12. Global Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angioedema Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Angioedema Treatment Sales by Region (2016-2021) & (K Units)
Table 16. Global Angioedema Treatment Sales Market Share by Region (2016-2021)
Table 17. Global Angioedema Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Angioedema Treatment Sales by Country (2016-2021) & (K Units)
Table 19. North America Angioedema Treatment Sales Market Share by Country (2016-2021)
Table 20. North America Angioedema Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Angioedema Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe Angioedema Treatment Sales by Country (2016-2021) & (K Units)
Table 23. Europe Angioedema Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe Angioedema Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Angioedema Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Angioedema Treatment Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Angioedema Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Angioedema Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Angioedema Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America Angioedema Treatment Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Angioedema Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America Angioedema Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Angioedema Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Angioedema Treatment Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Angioedema Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Angioedema Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Angioedema Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global Angioedema Treatment Sales (K Units) by Type (2016-2021)
Table 39. Global Angioedema Treatment Sales Market Share by Type (2016-2021)
Table 40. Global Angioedema Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global Angioedema Treatment Revenue Share by Type (2016-2021)
Table 42. Global Angioedema Treatment Price (USD/Unit) by Type (2016-2021)
Table 43. Global Angioedema Treatment Sales (K Units) by Application (2016-2021)
Table 44. Global Angioedema Treatment Sales Market Share by Application (2016-2021)
Table 45. Global Angioedema Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global Angioedema Treatment Revenue Share by Application (2016-2021)
Table 47. Global Angioedema Treatment Price (USD/Unit) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. AstraZeneca Angioedema Treatment Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. F.Hoffmann-La Roche AG Corporation Information
Table 54. F.Hoffmann-La Roche AG Description and Business Overview
Table 55. F.Hoffmann-La Roche AG Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. F.Hoffmann-La Roche AG Angioedema Treatment Product
Table 57. F.Hoffmann-La Roche AG Recent Developments/Updates
Table 58. Bausch Health Corporation Information
Table 59. Bausch Health Description and Business Overview
Table 60. Bausch Health Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Bausch Health Angioedema Treatment Product
Table 62. Bausch Health Recent Developments/Updates
Table 63. GlaxoSmithKline Corporation Information
Table 64. GlaxoSmithKline Description and Business Overview
Table 65. GlaxoSmithKline Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. GlaxoSmithKline Angioedema Treatment Product
Table 67. GlaxoSmithKline Recent Developments/Updates
Table 68. AstraZeneca Corporation Information
Table 69. AstraZeneca Description and Business Overview
Table 70. AstraZeneca Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. AstraZeneca Angioedema Treatment Product
Table 72. AstraZeneca Recent Developments/Updates
Table 73. Sanofi SA Corporation Information
Table 74. Sanofi SA Description and Business Overview
Table 75. Sanofi SA Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Sanofi SA Angioedema Treatment Product
Table 77. Sanofi SA Recent Developments/Updates
Table 78. Merck?Co Corporation Information
Table 79. Merck?Co Description and Business Overview
Table 80. Merck?Co Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Merck?Co Angioedema Treatment Product
Table 82. Merck?Co Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Angioedema Treatment Distributors List
Table 86. Angioedema Treatment Customers List
Table 87. Angioedema Treatment Market Trends
Table 88. Angioedema Treatment Growth Drivers
Table 89. Angioedema Treatment Market Restraints
Table 90. Global Angioedema Treatment Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Angioedema Treatment Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Angioedema Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Angioedema Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Angioedema Treatment Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Angioedema Treatment Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Angioedema Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Angioedema Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Angioedema Treatment Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Angioedema Treatment Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Angioedema Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Angioedema Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Angioedema Treatment
Figure 2. Global Angioedema Treatment Market Share by Type in 2020 & 2027
Figure 3. Antihistamines Product Picture
Figure 4. Corticosteroids Product Picture
Figure 5. Others Product Picture
Figure 6. Global Angioedema Treatment Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Research Organizations
Figure 10. Global Angioedema Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Angioedema Treatment Market Size 2016-2027 (US$ Million)
Figure 12. Global Angioedema Treatment Sales 2016-2027 (K Units)
Figure 13. Global Angioedema Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Angioedema Treatment Sales Share by Manufacturers in 2020
Figure 15. Global Angioedema Treatment Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Angioedema Treatment Players: Market Share by Revenue in 2020
Figure 17. Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Angioedema Treatment Sales Market Share by Region (2016-2021)
Figure 19. Global Angioedema Treatment Sales Market Share by Region in 2020
Figure 20. Global Angioedema Treatment Revenue Market Share by Region (2016-2021)
Figure 21. Global Angioedema Treatment Revenue Market Share by Region in 2020
Figure 22. U.S. Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Angioedema Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Angioedema Treatment by Type (2016-2021)
Figure 47. Sales Market Share of Angioedema Treatment by Application (2016-2021)
Figure 48. Sales Market Share of Angioedema Treatment by Application in 2020
Figure 49. Revenue Share of Angioedema Treatment by Application (2016-2021)
Figure 50. Revenue Share of Angioedema Treatment by Application in 2020
Figure 51. Manufacturing Cost Structure of Angioedema Treatment
Figure 52. Manufacturing Process Analysis of Angioedema Treatment
Figure 53. Angioedema Treatment Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.